Citadel Advisors
YDES

Citadel Advisors’s YD Bio Ltd YDES Stock Holding History

Citadel Advisors’s Portfolio YDES Stock Details YDES Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$150K Buy
19,450
+7,901
+68% +$76.3K ﹤0.01% 11682
2025
Q4 		$141K Buy
+11,549
New +$156K ﹤0.01% 11370

Other funds holding YDES

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors's YDES Position: Q1 2026 in Review

Citadel Advisors increased its YD Bio Ltd (YDES) stake by 68% in Q1 2026, buying an estimated $76.3K and bringing the position to 19,450 shares worth $150K. The position accounts for ﹤0.01% of the portfolio, ranked #11682.

Citadel Advisors first reported a position in YDES in Q4 2025 and has held it in 2 quarters since. 8 funds tracked by Wall St. Rank hold YDES as of Q1 2026.

  • Citadel Advisors held 19,450 shares of YD Bio Ltd worth $150K as of Q1 2026.
  • Citadel Advisors bought 7,901 YD Bio Ltd shares in Q1 2026, an estimated $76.3K.
  • YD Bio Ltd made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #11682 holding.
  • Citadel Advisors first reported a position in YD Bio Ltd in Q4 2025 and has held it in 2 quarters since.
  • 8 funds tracked by Wall St. Rank held YD Bio Ltd as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.